CD38 and malignant colon neoplasm: In colon cancer, Foxp3+ Tregs were classified into two subsets: CD38+Foxp3+ Tregs linked to negative prognosis, and CD38-Foxp3+ Tregs linked to positive survival.38 Given the distinct functions of each immune cell type, further research is crucial for accurately interpreting the immune results highlighted in this study.